BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for Press Releases

Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Markets Related Activities

By Leave a Comment

New York, NY, June 27, 2019 — Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of traumatic brain injuries (“TBIs”), including concussions and penetrating injuries, announced today the appointment of John N. Bonfiglio, PhD, MBA as its Chief Operating Officer. Qrons Inc. (OTC: QRON)

Dr. Bonfiglio’s primary responsibility will be to oversee all investigational new drug (“IND”) activities in the United States in coordination with Qrons’ Israeli-based scientific team. [Read more…]

ExCellThera enters into a manufacturing and collaboration agreement with New York Blood Center

By

MONTREAL, MAY 7, 2019 – ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that it has entered into a manufacturing and collaboration agreement with Comprehensive Cell Solutions (CCS), a division of New York Blood Center (NYBC) for the clinical grade production of ExCellThera’s lead cell therapy product, ECT-001. [Read more…]

ElevateBio to Create a Portfolio of Innovative Cell and Gene Therapy Companies

By

– ElevateBio to leverage its fully integrated, company building bench-to-bedside capabilities exclusively focused on cell and gene therapies

– ElevateBio’s BaseCamp, an R&D, process development and cGMP manufacturing subsidiary, provides cell and gene expertise for all ElevateBio portfolio companies and selected strategic partners

– $150 MM Series A financing co-led by UBS Oncology Impact Fund Managed by MPM Capital and F2 Ventures joined by EcoR1 Capital, Redmile Group, and Samsara BioCapital

ElevateBio, LLCCAMBRIDGE, Mass. — ElevateBio, a Cambridge-based biotechnology holding company, today announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and entrepreneurs. [Read more…]

BioInformant's World-Class Clients